Oxygen-Containing Groups on the Surface of Carbon Black von Studebaker, Merton L., Huffman, E. W. D., Wolfe, A. C., Nabors, L. G.

Volltext

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas von Lamb, Lawrence S., Pereboeva, Larisa, Youngblood, Samantha, Gillespie, G. Yancey, Nabors, L. Burton, Markert, James M., Dasgupta, Anindya, Langford, Catherine, Spencer, H. Trent

Volltext

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG von Blumenthal, Deborah T, Gorlia, Thierry, Gilbert, Mark R, Kim, Michelle M, Burt Nabors, L, Mason, Warren P, Hegi, Monika E, Zhang, Peixin, Golfinopoulos, Vassilis, Perry, James R, Hyun Nam, Do, Erridge, Sara C, Corn, Benjamin W, Mirimanoff, René O, Brown, Paul D, Baumert, Brigitta G, Mehta, Minesh P, van den Bent, Martin J, Reardon, David A, Weller, Michael, Stupp, Roger

Volltext

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy von Van Maaren, M.C., Hueting, T.A., van Uden, D.J.P., van Hezewijk, M., de Munck, L., Mureau, M.A.M., Seegers, P.A., Voorham, Q.J.M., Schmidt, M.K., Sonke, G.S., Groothuis-Oudshoorn, C.G.M., Siesling, S.

Volltext

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions von Miller, Julie J, Gonzalez Castro, L Nicolas, McBrayer, Samuel, Weller, Michael, Cloughesy, Timothy, Portnow, Jana, Andronesi, Ovidiu, Barnholtz-Sloan, Jill S, Baumert, Brigitta G, Berger, Mitchell S, Bi, Wenya Linda, Bindra, Ranjit, Cahill, Daniel P, Chang, Susan M, Costello, Joseph F, Horbinski, Craig, Huang, Raymond Y, Jenkins, Robert B, Ligon, Keith L, Mellinghoff, Ingo K, Nabors, L Burt, Platten, Michael, Reardon, David A, Shi, Diana D, Schiff, David, Wick, Wolfgang, Yan, Hai, von Deimling, Andreas, van den Bent, Martin, Kaelin, William G, Wen, Patrick Y

Volltext

Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS dru... von Grossman, Stuart A, Romo, Carlos G, Rudek, Michelle A, Supko, Jeffrey, Fisher, Joy, Nabors, L Burt, Wen, Patrick Y, Peereboom, David M, Ellingson, Benjamin M, Elmquist, William, Barker, Fred G, Kamson, David, Sarkaria, Jann N, Timmer, William, Bindra, Ranjit S, Ye, Xiaobu

Volltext

Human cytomegalovirus infection and expression in human malignant glioma von COBBS, Charles S, HARKINS, Lualhati, SAMANTA, Minu, GILLESPIE, G. Yancey, BHARARA, Suman, KING, Peter H, NABORS, L. Burt, COBBS, C. Glenn, BRITT, William J

Volltext

The RNA-binding protein HuR promotes glioma growth and treatment resistance von Filippova, Natalia, Yang, Xiuhua, Wang, Yimin, Gillespie, G Yancey, Langford, Cathy, King, Peter H, Wheeler, Crystal, Nabors, L Burt

Volltext

Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro von Han, Xiaosi, Li, Rong, Zhang, Wenbin, Yang, Xiuhua, Wheeler, Crystal G., Friedman, Gregory K., Province, Paula, Ding, Qiang, You, Zhiying, Fathallah-Shaykh, Hassan M., Gillespie, G. Yancey, Zhao, Xinyang, King, Peter H., Nabors, L. Burt

Volltext

A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses von Markert, James M, Razdan, Shantanu N, Kuo, Hui-Chien, Cantor, Alan, Knoll, Anette, Karrasch, Matthias, Nabors, L Burt, Markiewicz, Michael, Agee, Bonita S, Coleman, Jennifer M, Lakeman, Alfred D, Palmer, Cheryl A, Parker, Jacqueline N, Whitley, Richard J, Weichselbaum, Ralph R, Fiveash, John B, Gillespie, G Yancey

Volltext

Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression von BRANTLEY, Emily C, NABORS, L. Burton, GILLESPIE, G. Yancey, CHOI, Youn-Hee, PALMER, Cheryl Ann, HARRISON, Keith, ROARTY, Kevin, BENVENISTE, Etty N

Volltext

Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate von PLOTKIN, Scott R, BETENSKY, Rebecca A, HOCHBERG, Fred H, GROSSMAN, Stuart A, LESSER, Glenn J, NABORS, L. Burt, CHON, Brian, BATCHELOR, Tracy T

Volltext

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients von Horbinski, Craig, Ligon, Keith L, Brastianos, Priscilla, Huse, Jason T, Venere, Monica, Chang, Susan, Buckner, Jan, Cloughesy, Timothy, Jenkins, Robert B, Giannini, Caterina, Stupp, Roger, Nabors, L Burt, Wen, Patrick Y, Aldape, Kenneth J, Lukas, Rimas V, Galanis, Evanthia, Eberhart, Charles G, Brat, Daniel J, Sarkaria, Jann N

Volltext

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme von Peereboom, David M, Ahluwalia, Manmeet S, Ye, Xiaobu, Supko, Jeffrey G, Hilderbrand, Sarah L, Phuphanich, Surasak, Nabors, L Burt, Rosenfeld, Myrna R, Mikkelsen, Tom, Grossman, Stuart A

Volltext

The INFLUENCE 3.0 model: time-dependent risks of locoregional recurrence and contralateral breast cancer, now also including patients treated with neoadjuvant systemic therapy von van Maaren, M., Hueting, T., van Uden, D., van Hezewijk, M., de Munck, L., Zeillemaker, A., Schmidt, M., Sonke, G., Groothuis-Oudshoorn, C., Siesling, S.

Volltext

Lyn kinase activity is the predominant cellular Src kinase activity in glioblastoma tumor cells von STETTNER, Michelle R, WENQUAN WANG, NABORS, L. Burton, BHARARA, Suman, FLYNN, Daniel C, GRAMMER, J. Robert, GILLESPIE, G. Yancey, GLADSON, Candece L

Volltext

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells von Dixon, D A, Tolley, N D, King, P H, Nabors, L B, McIntyre, T M, Zimmerman, G A, Prescott, S M

Volltext

Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Ast... von Patel, Daxa M, Foreman, Paul M, Nabors, L Burt, Riley, Kristen O, Gillespie, G Yancey, Markert, James M

Volltext

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas von Holdhoff, Matthias, Ye, Xiaobu, Supko, Jeffrey G, Nabors, Louis B, Desai, Arati S, Walbert, Tobias, Lesser, Glenn J, Read, William L, Lieberman, Frank S, Lodge, Martin A, Leal, Jeffrey, Fisher, Joy D, Desideri, Serena, Grossman, Stuart A, Wahl, Richard L, Schiff, David

Volltext

Amyotrophic Lateral Sclerosis-linked Mutant SOD1 Sequesters Hu Antigen R (HuR) and TIA-1-related Protein (TIAR): IMPLICATIONS FOR IMPAIRED POST-TRANSCRIPTIONAL REGULATION OF VASCUL... von Lu, Liang, Wang, Shuying, Zheng, Lei, Li, Xuelin, Suswam, Esther A, Zhang, Xiaowen, Wheeler, Crystal G, Nabors, L.B, Filippova, Natalia, King, Peter H

Volltext